Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193244 | SCV000247547 | likely benign | not specified | 2016-11-18 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000193244 | SCV000340014 | benign | not specified | 2016-03-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001573815 | SCV000589917 | likely benign | not provided | 2018-05-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000969004 | SCV001116495 | likely benign | Methylmalonic acidemia with homocystinuria, type cblX | 2024-11-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001573815 | SCV005206908 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001573815 | SCV001800213 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000193244 | SCV001928169 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000193244 | SCV001966210 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003955154 | SCV004775401 | likely benign | HCFC1-related disorder | 2024-04-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |